Your browser doesn't support javascript.
loading
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl, Patrice M; Tissot, Alain C; Fulurija, Alma; Maurer, Patrik; Nussberger, Juerg; Sabat, Robert; Nief, Vera; Schellekens, Charlotte; Sladko, Katja; Roubicek, Kirsten; Pfister, Thomas; Rettenbacher, Manfred; Volk, Hans-Dieter; Wagner, Frank; Müller, Philipp; Jennings, Gary T; Bachmann, Martin F.
Affiliation
  • Ambühl PM; Renal Division, University Hospital, Zurich, Switzerland.
J Hypertens ; 25(1): 63-72, 2007 Jan.
Article in En | MEDLINE | ID: mdl-17143175
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Virion / Angiotensin II / Vaccines / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Hypertens Year: 2007 Type: Article Affiliation country: Switzerland
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Virion / Angiotensin II / Vaccines / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Hypertens Year: 2007 Type: Article Affiliation country: Switzerland